Journal of Clinical Microbiology · 2010 · 64 citations · 28 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMicrobial PathogenesisAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsEfflux-mediated ResistanceResistance GenesUrinary Tract InfectionsAntibiotic Efflux ResistanceAntibiotic Resistance GenesBacterial Efflux PumpsEfflux Pump GenesEfflux Pump OverexpressionEscherichia ColiEscherichia Coli ResistanceReverse Transcription Polymerase Chain Reaction (Rt-pcr)
Escherichia coli is one of the most common pathogens in urinary tract infections (UTIs), and antibiotic resistance in E. coli is becoming a serious problem in treating UTI. Efflux system overexpression is reported to contribute to E. coli resistance to several antibiotics. This study investigated the correlation of antibiotic susceptibilities with the overexpression of the efflux pump genes such as marA, yhiU, yhiV, and mdfA and with risk factors for antibiotic resistance in E. coli isolated from UTI patients. We examined the expression level of efflux pump genes using quantitative real-time reverse transcription-PCR (qRT-PCR). We also tested the in vitro susceptibilities to 12 kinds of antibiotics in 64 clinical strains of E. coli isolated from UTI patients. By multivariate analyses we revealed significant relationships between the overexpression of (i) marA and MICs of cefepime (FEP) and nalidixic acid (NAL), (ii) yhiV and MICs of minocycline (MIN), and (iii) mdfA and MICs of sitafloxacin (STX). In our investigation of the efflux pump genes, risk factors such as gender and the previous use of fluoroquinolones correlated with the overexpression of marA, and indwelling catheter use correlated with the overexpression of mdfA. In conclusion, we demonstrated that the increased expression of efflux pump genes such as marA and mdfA can lead to fluoroquinolone resistance in E. coli. These results contribute to our knowledge of the efflux system and raise the possibility of developing new agents, such as efflux pump inhibitors (EPIs), to antibiotic-resistant E. coli.
28
Martin Everett, Yongfeng Jin, Vito Ricci et al. · Antimicrobial Agents and Chemotherapy · 1996 · 364 citations · Full text
Patricia Komp Lindgren, Åsa Karlsson, Diarmaid Hughes · Antimicrobial Agents and Chemotherapy · 2003 · 357 citations · Full text
Hande Arslan, Özlem Kurt Azap, Önder Ergönül et al. · Journal of Antimicrobial Chemotherapy · 2005 · 289 citations · Full text